Oklo (NYSE: OKLO) announced that it achieved first criticality at its Groves Isotope Test Reactor in less than one year after groundbreaking, marking a major milestone for advanced nuclear deployment in the United States. The reactor will support commercial isotope production while serving as a foundation for Oklo's future powerhouse, isotope, and nuclear fuel cycle projects. Sector: Nuclear Energy / Advanced Reactors Key Highlights ⚛️ Achieved first criticality at the Groves Isotope Test Reactor 🚧 Reached the milestone in under one year after groundbreaking 🏭 Supports future commercial isotope production 🔋 Advances Oklo's powerhouse, isotope, and fuel cycle initiatives 🇺🇸 Marks a significant milestone for next-generation U.S. nuclear deployment Why It Matters Achieving first criticality demonstrates rapid execution of Oklo's advanced nuclear strategy and strengthens its position in the growing markets for clean energy, medical isotopes, and nuclear fuel technologies. Read More: https://www.thinksabio.com/reports/isr/OKLO